Skip to Content

Diagnostic Evaluation

A key element of the Consortium is providing translational research and diagnostics evaluation capacity at different and strategically relevant points in the development cycle, for commercial and research organisations, providing accessible evaluations for STI diagnostics. This work will be undertaken in close collaboration with our commercial partners and the Health Protection Agency through the existing GUMNET clinic network. We will conduct a number of trials, including those coming through the earlier phases of the pipeline and evaluations of ready to go diagnostics from industry. Robust testing, for new point of care devices will allow for FDA and European approval, increase potential for early market entry and provide a range of tools to enhance interventions for public health control of STIs.